Finance

Beta
Lists
4552:TYO
JCR Pharmaceuticals Co Ltd
¥466.00
+1.97%
(+9.00) 1D
Jun 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4552...
Open
¥449
High
¥468
Low
¥449
Mkt. cap
60.43B
Avg. vol.
687.69K
Volume
833.10K
Dividend
4.29%
Quarterly dividend
¥5
Ex-dividend date
Sep 29, 2025
P/E ratio
26.09
52-wk high
¥824
52-wk low
¥445
EPS
¥18
Shares outstanding
30.79M
No. of employees
987
Open
¥449
High
¥468
Low
¥449
Mkt. cap
60.43B
Avg. vol.
687.69K
Volume
833.10K
Dividend
4.29%
Quarterly dividend
¥5
Ex-dividend date
Sep 29, 2025
P/E ratio
26.09
52-wk high
¥824
52-wk low
¥445
EPS
¥18
Shares outstanding
30.79M
No. of employees
987
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to 4552 in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for 4552 in the last 3 months.
Highest
Current ¥466.00
¥900.00 (+93.13%)
Average
¥630.00 (+35.19%)
Lowest
¥450.00 (-3.43%)
News stories
From sources across the web
About JCR Pharmaceuticals Co Ltd
CEO-
Employees987
FoundedSep 13, 1975
Headquarters-
SectorPharmaceutical industry
Websitejcrpharm.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.57B
12.79B
8.99B
9.97B
Cost of goods sold
2.36B
1.97B
2.44B
3.37B
Cost of revenue
2.36B
1.97B
2.44B
3.37B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.82B
7.84B
8.50B
6.47B
Operating expense
6.86B
7.88B
8.54B
6.48B
Total operating expenses
9.21B
9.85B
10.98B
9.85B
Operating income
-644.00M
2.95B
-1.99B
116.00M
Other non operating income
17.00M
32.00M
49.00M
-65.00M
EBT including unusual items
-750.00M
3.29B
231.00M
452.00M
EBT excluding unusual items
-749.00M
3.07B
-1.69B
78.00M
Income tax expense
-180.00M
1.01B
142.00M
42.00M
Effective tax rate
24.00%
30.79%
61.47%
9.29%
Other operating expenses
-
-
-
-
Net income
-546.00M
2.26B
34.00M
434.00M
Net profit margin
-6.37%
17.63%
0.38%
4.35%
Earnings per share
-
-
-
-
Interest and investment income
29.00M
30.00M
33.00M
27.00M
Interest expense
-79.00M
-78.00M
-151.00M
-90.00M
Net interest expenses
-50.00M
-48.00M
-118.00M
-63.00M
Depreciation and amortization charges
38.00M
39.00M
36.00M
12.00M
EBITDA
199.50M
3.68B
-1.14B
755.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer